Kimia Biosciences Limited (BOM:530313)

Kimia Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 12, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	1,890	2,011	2,637	1,538	1,779	1,796
Market Cap Growth	-6.77%	-23.72%	71.48%	-13.56%	-0.92%	93.67%
Enterprise Value	2,244	2,406	3,205	2,079	2,253	2,224
Last Close Price	39.95	42.51	55.73	32.50	37.60	37.95
PE Ratio	23.12	20.92	-	-	-	35.18
PS Ratio	1.50	1.69	2.51	1.20	1.42	1.35
PB Ratio	16.32	20.18	796.60	28.15	11.95	9.74
P/TBV Ratio	24.74	20.23	908.91	28.59	12.07	9.79
P/FCF Ratio	23.45	12.03	20.24	-	40.28	-
P/OCF Ratio	13.76	9.44	18.14	-	22.25	30.09
EV/Sales Ratio	1.78	2.02	3.06	1.62	1.80	1.68
EV/EBITDA Ratio	12.33	11.98	1176.42	-	372.40	26.71
EV/EBIT Ratio	15.35	14.26	-	-	-	34.39
EV/FCF Ratio	27.84	14.40	24.60	-	51.01	-
Debt / Equity Ratio	3.12	3.95	149.59	10.66	3.06	2.68
Debt / EBITDA Ratio	1.98	1.95	176.14	-	75.21	5.92
Debt / FCF Ratio	4.48	2.36	3.80	-	10.30	-
Net Debt / Equity Ratio	3.05	3.93	149.14	10.62	3.04	2.65
Net Debt / EBITDA Ratio	1.96	1.95	181.23	-19.32	74.77	5.86
Net Debt / FCF Ratio	4.39	2.34	3.79	-6.05	10.24	-6.42
Asset Turnover	-	1.13	0.95	1.11	1.16	1.38
Inventory Turnover	-	2.21	1.94	2.29	3.08	4.45
Quick Ratio	0.40	0.46	0.41	0.41	0.55	0.87
Current Ratio	0.91	0.92	0.88	1.08	1.18	1.41
Return on Equity (ROE)	-	186.70%	-183.25%	-91.91%	-22.22%	32.09%
Return on Assets (ROA)	-	9.99%	-1.67%	-3.40%	-1.32%	4.20%
Return on Invested Capital (ROIC)	21.50%	24.07%	-5.24%	-10.15%	-3.60%	10.11%
Return on Capital Employed (ROCE)	49.10%	57.40%	-9.70%	-14.00%	-4.80%	11.60%
Earnings Yield	4.33%	4.78%	-2.01%	-6.08%	-2.08%	2.84%
FCF Yield	4.26%	8.31%	4.94%	-6.23%	2.48%	-4.23%
Buyback Yield / Dilution	0.64%	-	-	-	-	-13.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.